Gollob Jared

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$15.54M

Insider Activity of Gollob Jared

According to the SEC Form 4 filings, Gollob Jared, being in a position of

  1. Chief Medical Officer at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 45340 shares for $1.98M,
    over all time since 2021-02-17, has bought 0 shares, and sold 304012 shares for $15.54M.

The largest sale of all time was on 2021-11-01 and amounted to 42497 shares of Kymera Therapeutics, Inc. for $2.63M.

Biography of Gollob Jared

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,977,9293100

Comparison of Insiders on Amount of Buys and Sells

2025-03-03SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
5,740
0.009%
$30.45$174,786+9.33%
2024-07-16SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
23,145
0.0578%
$45.81$1.06M-9.99%
2024-07-15SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
16,455
0.0405%
$45.15$742,925-3%
2024-03-04SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
3,344
0.0054%
$41.86$139,967-3.98%
2024-02-27SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
400
0.0007%
$45.00$18,000-4.89%
2024-02-09SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
46,137
0.0835%
$35.50$1.64M+12.6%
2023-03-02SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
1,298
0.0021%
$31.00$40,233-24.5%
2021-11-02SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
14,996
0.0303%
$63.22$948,063-50.1%
2021-11-01SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
42,497
0.0867%
$61.78$2.63M-48.28%
2021-03-15SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
20,610
0.0463%
$60.17$1.24M-13.14%
2021-03-11SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
9,390
0.0213%
$60.05$563,878-11.4%
2021-02-24SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
17,350
0.0386%
$50.91$883,342+2.99%
2021-02-23SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
38,570
0.0851%
$49.65$1.92M+4.68%
2021-02-22SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
18,208
0.0411%
$52.63$958,260+1.07%
2021-02-19SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
17,774
0.0401%
$55.09$979,118-3.49%
2021-02-18SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
12,998
0.0292%
$55.94$727,081-5.2%
2021-02-17SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
15,100
0.0333%
$58.39$881,672-10.51%
Total: 17
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD